Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sana Biotechnology, Inc.

2.81
-0.0600-2.09%
Post-market: 2.820.0100+0.36%19:43 EDT
Volume:5.97M
Turnover:16.89M
Market Cap:633.81M
PE:-3.18
High:2.90
Open:2.90
Low:2.79
Close:2.87
Loading ...
Jun 23, 2025

Major Issues Report

Form 8-K - Current report
Jun 06, 2025

Major Issues Report

Form 8-K - Current report
May 08, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2025

Major Issues Report

Form 8-K - Current report
Mar 17, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 17, 2025

Major Issues Report

Form 8-K - Current report
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 16, 2025

Proposed Sale Of Securities

Form 144 | Sana Biotechnology's Officer Christian Hordo proposes to sell 75,000 shares with a total value of approximately $289,500.
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Dec 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 26, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 25, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 08, 2024

Major Issues Report

Form 8-K - Current report
Oct 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 08, 2024

Major Issues Report

Form 8-K - Current report
Sep 25, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities